NATIONAL
HEALTHCARE 2023

Business programme

MEDICAL SCIENCE AT THE FOREFRONT OF RUSSIA’S TECHNOLOGICAL SOVEREIGNTY

01.12.2023
16:15–17:45
VDNH, 75 pavilion, Hall of closed business events, 2nd floor

The rapid development of medical science in Russia is contributing to significant achievements in the medical and pharmaceutical industries, improving genomic technologies and the production of innovative drugs, and creating unparalleled medical technologies and equipment. However, to achieve technological sovereignty in the healthcare industry, it is crucial to enhance the level of interaction between the scientific community, government, and business and prioritize areas of focus and projects that aim to create a specific tangible and practice-oriented result or product that is promising in terms of industrial production and its introduction in clinical practice. Implementing these ambitious goals will help achieve the strategic goals of reducing dependence on imports, modernizing Russia’s domestic production capacities, and ensuring a consistently high level of national healthcare regardless of external factors. How can we overcome the challenges that medical science will encounter on the path to achieving Russia’s complete technological sovereignty in the healthcare industry? What areas of medical science should be regarded as the top priorities and the most promising? How do developments with AI affect the development of the healthcare system? What government incentives are needed right now to get the scientific community and the medical and pharmaceutical industries completely focused on ensuring technological sovereignty in the healthcare sector?

Moderator

Panellists

Aleksandr Gintsburg

Director, "National Research Center for Epidemiology and Microbiology named after the honorary academician N.F. Gamaleya" of the Ministry of Health of the Russian Federation

Born on November 10th,1951 in Moscow. In 1974 graduated from Lomonosov Moscow State University, then took post-graduate course at State Research Institute of genetics and selection of industry-related microorganisms, doctor of biological sciences, professor. Since 1997. headed by State Scientific Research Institute of Epidemiology and Microbiology. Gamalei RAMS. Is the head of the lab genetically engineered pathogens NIIEM im.N.F.Gamalei RAMS. Awarded the Certificate of Merit of the Russian Federation, the Honorary Diploma of Medical Sciences, P.Erliha medal, the medal "In memory of the 850th anniversary of PEF" Currently, AL Gunzburg - one of the leading experts in the field of molecular biology and genetics of pathogens, the author of over 300 scientific works, including two monographs. Scientific-practical and pedagogical activity Ginzburg AL combined with a great social work. He chairs the Scientific Council of the Institute and is chairman of Specialized Council for the Protection of candidate and doctoral dissertations in the field of "Microbiology" and "Immunology and Allergology". Alexander Leonidovich is a member of the editorial boards of leading Russian journals in medical microbiology - "Journal of Microbiology, Epidemiology and Immunology" and "Molecular Genetics, Microbiology and Virology." Member of the Scientific Council of the Ministry of Health of the Presidium of Russia, head of the section "Microbiology".

Aydar Ishmukhametov

Director General, Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences

He has graduated (in 1980) the First Moscow State Medical University (Sechenov University), where he later worked (1980-2012).
He is the Candidate of Medical Science (1985) and the Doctor of Medicine (2001).
Since 2013 – the Director General of the Federal State Budgetary Scientific Institution «Chumakov Federal Scientific Center for Research & Development of Immune-and-Biological Product» (FSBSI Chumakov FSC R&D IBP RAS) of the Ministry of Science and Higher Education (Russia). Since 2017 – the head of the subdepartment of the organization and technology of immunobiological preparations production of the First Moscow State Medical University.
Was chosen as the RAS corresponding member in medical sciences department («Pharmacy Organization» specialty) (2016).
Under the leadership of A.A. Ishmukhametov there was developed a unique methodology for the production of information and analytical systems reflecting the actual state of the pharmaceutical industry. It includes the latest statistical data processing techniques and data extrapolation algorithms adapted to the characteristics of the pharmaceutical market. Creation of a fundamentally new analytical content, enabling multifactor analysis and scientific forecasting of economic phenomena in the pharmaceutical market, makes it possible to more effectively solve the problems of the industry. There are formulated and substantiated the basic principles of creating a unified information environment in the field of circulation of medicines.
In 2014, he proposed and implemented the Chumakov Center development concept, which made it possible to combine the scientific, technological and production aspects of creating and introducing into the circulation the original innovative national immunobiological preparations, such as prevention vaccines for the polio, tick-borne encephalitis, yellow fever, which are included in regional immunization calendars. The reorganization of the enterprise’s business processes has carried out with the introduction of quality management principles in biopharmaceutical enterprises. This has made it possible in the shortest possible time to completely modernize the enterprise, obtain a GMP certificate, solve the problems of import substitution and to develop new biopharmaceutical and immunological preparations, some of which have already passed preclinical and clinical studies. As the result, the company has increased its output and exports of the preparations.